1-64777800-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001366165.2(RAVER2):āc.494A>Gā(p.Tyr165Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000153 in 1,614,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000085 ( 0 hom., cov: 32)
Exomes š: 0.00016 ( 0 hom. )
Consequence
RAVER2
NM_001366165.2 missense
NM_001366165.2 missense
Scores
3
9
7
Clinical Significance
Conservation
PhyloP100: 5.83
Genes affected
RAVER2 (HGNC:25577): (ribonucleoprotein, PTB binding 2) Enables RNA binding activity. Predicted to be involved in regulation of alternative mRNA splicing, via spliceosome. Predicted to be located in cytoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.789
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAVER2 | NM_001366165.2 | c.494A>G | p.Tyr165Cys | missense_variant | 3/12 | ENST00000294428.8 | NP_001353094.1 | |
RAVER2 | NM_018211.4 | c.494A>G | p.Tyr165Cys | missense_variant | 3/12 | NP_060681.2 | ||
RAVER2 | XM_011541706.3 | c.494A>G | p.Tyr165Cys | missense_variant | 3/9 | XP_011540008.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAVER2 | ENST00000294428.8 | c.494A>G | p.Tyr165Cys | missense_variant | 3/12 | 5 | NM_001366165.2 | ENSP00000294428 | A2 | |
RAVER2 | ENST00000371072.8 | c.494A>G | p.Tyr165Cys | missense_variant | 3/12 | 1 | ENSP00000360112 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152220Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
13
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000108 AC: 27AN: 249414Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135308
GnomAD3 exomes
AF:
AC:
27
AN:
249414
Hom.:
AF XY:
AC XY:
20
AN XY:
135308
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000160 AC: 234AN: 1461798Hom.: 0 Cov.: 31 AF XY: 0.000161 AC XY: 117AN XY: 727198
GnomAD4 exome
AF:
AC:
234
AN:
1461798
Hom.:
Cov.:
31
AF XY:
AC XY:
117
AN XY:
727198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74370
GnomAD4 genome
AF:
AC:
13
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
16
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | The c.494A>G (p.Y165C) alteration is located in exon 3 (coding exon 3) of the RAVER2 gene. This alteration results from a A to G substitution at nucleotide position 494, causing the tyrosine (Y) at amino acid position 165 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Loss of loop (P = 0.1242);Loss of loop (P = 0.1242);
MVP
MPC
0.52
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at